HEATHER HOKANSON: Open Payments
NPI 1417109844 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 98 payments from 17 companies in 2025. Trend: 2023 $1,463 · 2024 $1,513 · 2025 $1,736
Food & beverage: $1,736
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $334 |
| PFIZER INC. | 15 | $221 |
| Phathom Pharmaceuticals, Inc. | 6 | $212 |
| Corcept Therapeutics | 8 | $200 |
| GlaxoSmithKline, LLC. | 6 | $173 |
| Novo Nordisk Inc | 13 | $167 |
| Lilly USA, LLC | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
Products named: VOQUEZNA, Korlym, PREVNAR 20, QULIPTA, VRAYLAR, SHINGRIX, UBRELVY, Ozempic.
Industry payments across WA — which companies pay providers there.
